Roth Capital Maintains Buy on Gentherm, Lowers Price Target to $39

Benzinga Newsdesk www.benzinga.com Negative 62.7%

Neg 62.7% Neu 0% Pos 0%

Roth Capital analyst Matt Koranda maintains Gentherm (NASDAQ:THRM) with a Buy and lowers the price target from $44 to $39.